Analysis for B3 (Brasil Bolsa Balcão)
Analysis summary
B3 (Brasil Bolsa Balcão) (B3SA3.BR) currently has a total score of 61 points, placing it in the strong range. The score is made up of Performance (57), Stability (50) and Trend (88). The profile is clearly uneven: Trend stands out while Stability is more neutral.
Performance scores 57 points (neutral). Key strength: 1Y return at 56.2 %. Weaker metric: 5Y return at -11.2 %. This points to a sharper upswing more recently.
Stability scores 50 points (neutral). Key strength: Sharpe ratio (90d) at 1.82. Weaker metric: max drawdown (3Y) at -53.9 %. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 88 points (very strong). Key strength: Price is about 16.0 % above SMA50. Even the weakest metric remains solid in absolute terms: relative strength (12M) at 28.8 %.
Overall, the profile has a clear strength in Trend, while Stability is the main limiter. On a metric level, SMA50 distance stands out, while 5Y return lags.
(Historical evaluation, not investment advice.)
Metrics
Performance
Stability
FAQ
- What investor type does B3 (Brasil Bolsa Balcão) fit best in FoxScore?
- B3 (Brasil Bolsa Balcão) fits a trend/momentum-oriented investor type in FoxScore: trend is clearly the strongest sub-score. This can be useful if you follow trends — but pay close attention to stability (drawdowns/volatility) because trend signals can flip quickly.
- How meaningful is the available history for B3 (Brasil Bolsa Balcão)?
- B3 (Brasil Bolsa Balcão) currently has about 15 years of price history since it started trading. That’s a solid base to interpret returns, drawdowns and trend behavior since launch — earlier market crises happened before the asset existed and are therefore not part of its history.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.